| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/25/2002 | WO2001096400A3 52871, a novel human g protein coupled receptor and uses thereof |
| 04/25/2002 | WO2001094417A3 Novel human seven transmembrane proteins and polynucleotides encoding the same |
| 04/25/2002 | WO2001094392A3 Recombinant subunit proteins from porcine parvovirus produced in plants |
| 04/25/2002 | WO2001094387A3 Epididymis-specific proteins with fibronectin type ii modules |
| 04/25/2002 | WO2001093805A3 FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS |
| 04/25/2002 | WO2001088136A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2001088122A3 Erg modulators |
| 04/25/2002 | WO2001085782A3 Fusion receptor from TNF family |
| 04/25/2002 | WO2001083791A3 Identification and characterization of a pagoda phenotype (PGD) in plants |
| 04/25/2002 | WO2001083683A3 A novel polypeptide, a human pax protein 11.3 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2001083528A3 Nucleic acid immunization |
| 04/25/2002 | WO2001081539A3 A novel polypeptide, a human zinc ion transport protein 26 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2001081538A3 A novel polypeptide, a human connexin 9 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2001077348A3 Ketogulonigenium endogenous plasmids |
| 04/25/2002 | WO2001075072A3 Production of TcR gamma delta T cells |
| 04/25/2002 | WO2001074853A3 Methods and products for regulating cell motility |
| 04/25/2002 | WO2001072957A3 Fibroblast growth factor-like molecules and uses thereof |
| 04/25/2002 | WO2001072831A3 Immunoregulator |
| 04/25/2002 | WO2001072782A3 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/25/2002 | WO2001072776A3 Agent and method for reducing intraocular pressure |
| 04/25/2002 | WO2001062927A3 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics |
| 04/25/2002 | WO2001062922A3 Polypeptides and corresponding molecules for disease detection and treatment |
| 04/25/2002 | WO2001062908A3 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 04/25/2002 | WO2001061010A3 GTPASE activating proteins |
| 04/25/2002 | WO2001060975A3 Gene disruption methodologies in fungi for drug target discovery |
| 04/25/2002 | WO2001060848A3 Conjugates targeted to target receptors |
| 04/25/2002 | WO2001060847A3 avirulent, immunogenic flavivirus chimeras |
| 04/25/2002 | WO2001059453A3 Biosensor compositions and methods of use |
| 04/25/2002 | WO2001058940A3 Adenoviral capsid containing chimeric protein IX |
| 04/25/2002 | WO2001051628A3 Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/25/2002 | WO2001047951A3 Angiopoietin analogs |
| 04/25/2002 | WO2001044476A3 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of carbohydrates |
| 04/25/2002 | WO2001042471A3 Polypeptides and polynucleotides encoding same |
| 04/25/2002 | WO2001031017A3 Plants with a modified flower and seed development |
| 04/25/2002 | WO2000029622A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/25/2002 | US20020049998 Cytoplasmic male sterility system production canola hybrids |
| 04/25/2002 | US20020049995 Nucleic acid encoding GAI gene of arbidopsis thaliana |
| 04/25/2002 | US20020049993 Maize rhoGTPase-activating protein (rhoGAP) polynucleotides and methods of use |
| 04/25/2002 | US20020049989 Transgenic mice containing stefin homolog protease inhibitor gene disruptions |
| 04/25/2002 | US20020049988 Transgenic animals harboring APP allele having swedish mutation |
| 04/25/2002 | US20020049987 Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof |
| 04/25/2002 | US20020049712 Method for detection of prostate specific membrane antigen in serum |
| 04/25/2002 | US20020049404 Fas ligand expressing antigen presenting cells for tolerance induction |
| 04/25/2002 | US20020049313 Method for introducing foreign material into higher eukaryotic cells |
| 04/25/2002 | US20020049312 Noel human thrombospondin-like proteins and polynucleotides encoding the same |
| 04/25/2002 | US20020049307 Selective labeling and isolation of phosphopeptides and applications to proteome analysis |
| 04/25/2002 | US20020049306 Differentiation-suppressive polypeptide |
| 04/25/2002 | US20020049304 Human CCN-like growth factor |
| 04/25/2002 | US20020049300 Enzymatic proteins for use in diagnosis and treatment of immune response defects |
| 04/25/2002 | US20020049177 Detecting an aberrant level or bioactivity of or screening for a Wnt pathway component or a frizzled related protein gene product |
| 04/25/2002 | US20020049176 Administration of an agent that promotes mitochondrial biogenesis by induction of a PGC gene and/or a nuclear regulatory factor gene; Screening assays for agents that regulate such genes |
| 04/25/2002 | US20020049159 Methods and compositions for the treatment of motor neuron injury and neuropathy |
| 04/25/2002 | US20020049153 Modified peptides capable of forming covalent bonds with one or more blood components, especially albumin, to form a conjugate; administered to treat humans with diabetes |
| 04/25/2002 | US20020049151 Therapeutic approaches to diseases by suppression of the NURR subfamily of nuclear transcription factors |
| 04/25/2002 | US20020048816 Genetically engineered cell; for use as a vaccine; for use in screening polypeptides and antigens; for use as a support for immobilizing an enzyme, peptide or antigen |
| 04/25/2002 | US20020048815 Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression |
| 04/25/2002 | US20020048814 Reducing gene expression in eukaryotic cells; obtain cells, incubate with modulator, monitor cells for decreased gene expression |
| 04/25/2002 | US20020048813 Methods and products for regulating cell motility |
| 04/25/2002 | US20020048812 Isolation and in vitro differentiation of conditionally immortalized murine olfactory receptor neurons |
| 04/25/2002 | US20020048811 Polypeptide for use in in situ detection and drug screening |
| 04/25/2002 | US20020048805 Feline immunodeficiency virus gene therapy vectors |
| 04/25/2002 | US20020048804 Human translation protein; for use in the treatment of cancer |
| 04/25/2002 | US20020048800 Myosin-like gene expressed in human heart and muscle |
| 04/25/2002 | US20020048799 Insecticidal protein fragments |
| 04/25/2002 | US20020048795 Nucleotide sequences coding enzymatic polypeptides; for use in the fermentative generation of preferential amino acids |
| 04/25/2002 | US20020048794 Polypeptides for use in the diagnosis and treatment of skin disorders, cancer, vision and demyelination defects, inflammation, glomerculonephritis, Kaposi's sarcoma, angiogenesis, sarcoidosis, osteoarthritis and aneurysm |
| 04/25/2002 | US20020048792 Methods and materials for regulated production of proteins |
| 04/25/2002 | US20020048791 Nucleotide sequences coding preferential polypeptides; for use in the treatment of dietetics, diabetes, anxiety, hypertension, drug dependence, congestive heart failure, cardiovascular disorders, tumors and nervous system disorders |
| 04/25/2002 | US20020048790 Nucleotide sequences coding binding protein for use in the prevention of infections; bactericides |
| 04/25/2002 | US20020048789 birA |
| 04/25/2002 | US20020048788 FtsA |
| 04/25/2002 | US20020048787 Peptides; for use in development of human therapeutics and diagnostic testing |
| 04/25/2002 | US20020048786 Nucleotide sequences for use in the treatment of infections, arthritis, karposi's sarcoma, allergies, asthma, nervous system and autoimmune diseases |
| 04/25/2002 | US20020048785 Novel polypeptides within the tumor necrosis factor receptor superfamily and uses therefor |
| 04/25/2002 | US20020048784 Prostatic growth factor |
| 04/25/2002 | US20020048777 Nucleotide sequences for use in therapy, monitoring and screning preferential tumors |
| 04/25/2002 | US20020048769 Protein-protein interactions in neurodegenerative disorders |
| 04/25/2002 | US20020048764 Human PEM as a target for birth contol and treatment of Alzheimer's disease |
| 04/25/2002 | US20020048763 Nucleotide sequences for use in the detection of transcription patterns in preferential tissues |
| 04/25/2002 | US20020048759 Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer |
| 04/25/2002 | US20020048745 Nucleotide sequences coding fertilization protein; for use in artifical fertilization |
| 04/25/2002 | US20020048590 Vaccine comprises a unit dose of an anthrax protective antigen and a specific antigen bound to an anthrax protective antigen binding protein. |
| 04/25/2002 | US20020048585 Decreasing syndecan-4 expression, level, or activity |
| 04/25/2002 | US20020048571 Chimeric polypeptides of serum albumin and uses related thereto |
| 04/25/2002 | US20020048565 Mammalian tolloid-like gene and protein |
| 04/25/2002 | US20020048271 Methods and composition for restoring conformational stability of a protein of the p53 family |
| 04/25/2002 | DE10052492A1 Genetically modified monocotyledon plant cell useful for synthesis of modified starch, comprises an extraneous polynucleotide that codes for a protein with the biological activity of an R1 protein from Solanum tuberosum |
| 04/25/2002 | DE10050873A1 New metal-binding proteins isolated from cereal seedling extracts, useful for removing and recovering heavy metals from fluid media |
| 04/25/2002 | DE10050091A1 New casein-derived peptide with growth promoting activity, useful as additive for eukaryotic cell cultures and for recombinant protein production |
| 04/25/2002 | DE10048626A1 New nucleic acid encoding soluble cytokine receptor, useful for diagnosis and treatment of e.g. immune disease, also related protein and antibodies |
| 04/25/2002 | DE10045123A1 New transcription factor gene from Candida albicans, and its related polypeptide and antibody, useful for diagnosis and treatment of candida infection and for drug screening |
| 04/25/2002 | CA2464092A1 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | CA2453140A1 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
| 04/25/2002 | CA2426698A1 Method for producing proteins by electroporation |
| 04/25/2002 | CA2426624A1 Human cyclic nucleotide binding protein |
| 04/25/2002 | CA2426460A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 04/25/2002 | CA2426424A1 Haemophilus influenzae basb206 gene and protein |
| 04/25/2002 | CA2426413A1 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae |
| 04/25/2002 | CA2426371A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | CA2426312A1 Compositions and methods for modulating rsv infection and immunity |